Chimeric Therapeutics Ltd (CHM) — Cash Flow Quality Index

Latest as of December 2023: -3.81x

Chimeric Therapeutics Ltd (CHM) has a Cash Flow Quality Index of -3.81x as of December 2023. Operating cash flow of AU$-4.66 Million is below net income of AU$1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Chimeric Therapeutics Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-3.81x

Operating CF / Net Income

Operating Cash Flow

AU$-4.66 Million

AUD

Net Income

AU$1.22 Million

AUD

Data as of

Dec 2023

Most recent filing

Annual Cash Flow Quality Index for Chimeric Therapeutics Ltd (None–None)

Year-by-year earnings quality comparison for Chimeric Therapeutics Ltd.

Year	Quality Index	Operating CF (AUD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.